CircRNA mmu_circ_0000021 regulates microvascular function via the miR-143-3p/NPY axis and intracellular calcium

Jingjie Xiong1, Yisen Hu2, Yi Liu3

  • 1Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Cell Death Discovery
|July 12, 2022
PubMed

Insights

This study identifies a novel circular RNA, mmu_circ_0000021, that repairs microvascular dysfunction after cardiac ischemia-reperfusion injury. It regulates NPY via miR-143-3p, restoring cardiac function.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • RNA Biology

Background:

  • Cardiac ischemia-reperfusion (I/R) injury leads to significant complications.
  • Restoring microvascular function is critical for cardiac repair after I/R.
  • The molecular mechanisms of circular RNAs (circRNAs) in repairing microvascular dysfunction remain unclear.

Purpose of the Study:

  • To investigate the role of circRNAs in cardiac microvascular dysfunction following I/R injury.
  • To identify specific circRNAs involved in regulating microvascular function.
  • To elucidate the molecular mechanisms by which identified circRNAs impact cardiac repair.

Main Methods:

  • High-throughput RNA sequencing and qRT-PCR to identify differentially expressed circRNAs.
  • circRNA knockdown and overexpression studies to assess functional roles.
  • Dual-luciferase assays, RNA pull-down, and RIP to analyze molecular interactions.
  • Immunohistochemistry, transmission electron microscopy, and immunofluorescence to evaluate microvascular changes.

Main Results:

  • Identified 80 up-regulated and 54 down-regulated circRNAs in cardiac I/R injury.
  • mmu_circ_0000021 was identified as a key differentially expressed circRNA.
  • mmu_circ_0000021 regulates microvascular dysfunction by targeting NPY via miR-143-3p.
  • This mechanism involves regulating microvascular spasm and restoring cardiac function.

Conclusions:

  • mmu_circ_0000021 plays a crucial role in mitigating cardiac microvascular dysfunction post-I/R injury.
  • The identified circRNA-miRNA-mRNA axis (mmu_circ_0000021/miR-143-3p/NPY) offers a novel therapeutic target.
  • Understanding this pathway is vital for developing strategies to improve outcomes after I/R injury.